Metabolic Syndrome Resposne to Dietary Limitations in Familial Mediterranean Fever in Adolescents
1 other identifier
interventional
40
1 country
1
Brief Summary
metabolic syndrome may be prevalent in familial Mediterrean fever. Dietary limitations are main treatment in metabilc syndrome
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 10, 2026
CompletedFirst Submitted
Initial submission to the registry
September 16, 2026
CompletedFirst Posted
Study publicly available on registry
September 22, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 15, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 15, 2026
September 22, 2026
September 1, 2026
4 months
September 16, 2026
September 16, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
fasting blood glcuose
it will be assessed in plasma
it will be assessed after 12 weeks
Secondary Outcomes (7)
body mass index
it will be assessed after 12 weeks
waist circumference
it will be assessed after 12 weeks
high density lipoprotein
it will be assessed after 12 weeks
triglycerides
it will be assessed after 12 weeks
systolic blood pressure
it will be assessed after 12 weeks
- +2 more secondary outcomes
Study Arms (2)
group I
EXPERIMENTALtwenty metabolic syndrome participants (adolescents) with familial Mediterrean fever will received low calorie diet for 3 months
group II
NO INTERVENTIONTwenty metabolic syndrome participants (adolescents) with familial Mediterrean fever will no change their dietary habits for 12 weeks
Interventions
metabolic syndrome participants (adolescents) with familial Mediterrean fever will received low calorie diet for 3 months
Eligibility Criteria
You may qualify if:
- metabolic syndrome
- familial mediterreanean fever
You may not qualify if:
- cardiac diseases
- repsiratory diseases
- tumors
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Cairo University
Giza, Dokki, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ali MA Ismail, PHD
Cairo University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- lecturer of department of physical therapy for cardiovascular respiratory disorder and geriatrics
Study Record Dates
First Submitted
September 16, 2026
First Posted
September 22, 2026
Study Start
August 10, 2026
Primary Completion (Estimated)
December 15, 2026
Study Completion (Estimated)
December 15, 2026
Last Updated
September 22, 2026
Record last verified: 2026-09